OmniSeq News

Dr. Carl Morrison featured in Future of Personal Health

Dr. Morrison, president of OmniSeq℠ Precision Medicine Technology, is featured as a “leading voice” in precision medicine. Buffalo, NY – June 29, 2015—The digital publication Future of Personal Health focuses on precision medicine in an article entitled...

read more

OmniSeq LLC: A Unique Approach to Personalized Medicine

By Alan Rosenhoch, Featuring Carl Morrison, MD, DVM Dr. Carl Morrison is founder, president and chief scientific officer of OmniSeq LLC – a recent Roswell Park Cancer Institute spinoff genomics firm. At Roswell Park, Dr. Morrison continues in his roles as Executive...

read more

Covaris, Inc. and OmniSeq, LLC Today Announced truXTRAC™ FFPE DNA Extraction and Purification Kit as the Method of Choice for Obtaining Clinical-Grade DNA from FFPE Samples for Use with OmniSeq Target℠ Testing

WOBURN, Mass., Sept. 1, 2015 /PRNewswire/ — truXTRAC is a comprehensive novel solution for clinical-grade DNA extraction from Formalin-Fixed, Paraffin-Embedded (FFPE) tissues utilizing Covaris Adaptive Focused Acoustics® (AFA™) technology. The unique focused,...

read more

Follow Us on Twitter

Dr. Sean Glenn speaking in packed house at #SITC2018 on microsatellite instability by (NGS) Next Generation Sequencing.


Grace Dy, M.D. giving her talk at the SITC Immune Escape Program.


Immune Report Card®: New Test Matches Patients With Immunotherapies Likely to Work Best | Roswell Park Comprehensive Cancer Center

Proud that OmniSeq has met the rigorous standards needed to become an NCI-MATCH participating lab. Working hard with our colleagues at LabCorp to bring this testing to NCORP sites across the country!

OmniSeq Advance "All I Want": via @YouTube

Load More...